-+ 0.00%
-+ 0.00%
-+ 0.00%

Nykode Therapeutics Presents DNA Vaccine Platform at Personalized Cancer Vaccine Summit

PUBT·11/19/2026 13:36:49
Listen to the news
Nykode Therapeutics Presents DNA Vaccine Platform at Personalized Cancer Vaccine Summit
  • Nykode Therapeutics will showcase its APC-targeted DNA vaccine platform at the 3rd Annual Personalized Cancer Vaccine Summit in Boston, December 1-3, 2026.
  • CEO Michael Engsig will lead a personalized cancer vaccine manufacturing workshop on December 1 at 9 a.m.
  • Chief Scientific Officer Agnete Fredriksen will present on next-generation personalized cancer vaccines on December 3 at 9 a.m.
  • Fredriksen will join a panel comparing personalized versus off-the-shelf cancer vaccines on December 3 at 11:30 a.m.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nykode Therapeutics AS published the original content used to generate this news brief via NewsWeb, the disclosure sustem operated by Euronext Oslo (Ref. ID: 202611190830OSLOBORSNEWS__EN_F5632DFDCBB10958BC313CCB87A2235), on November 19, 2026, and is solely responsible for the information contained therein.